Array
(
    [results] => Array
        (
            [0] => Array
                (
                    [ArticleID] => 509392
                    [Title] => Abbott Laboratories acquires Belgian chemical maker for $6.6 billion
                    [Summary] => 
Abbott Laboratories on Monday said it would pay $6.6 billion for the pharmaceutical business of Belgian chemicals maker Solvay in a move to further expand internationally and add to its product portfolio.
                    [DatePublished] => 2009-09-30 00:00:00
                    [ColumnID] => 133272
                    [Focus] => 0
                    [AuthorID] => 
                    [AuthorName] => 
                    [SectionName] => Business
                    [SectionUrl] => business
                    [URL] => 
                )

            [1] => Array
                (
                    [ArticleID] => 175716
                    [Title] => New hope for women having miscarriages
                    [Summary] => The role of dydrogesterone (Duphaston) in reducing habitual abortions or recurrent miscarriages by making the immune system more receptive to pregnancy was recently discussed at a satellite symposium organized by Solvay Pharmaceuticals at the 9th World Congress of Gynecological Endocrinology in Hong Kong.


                    [DatePublished] => 2002-09-12 00:00:00
                    [ColumnID] => 133272
                    [Focus] => 0
                    [AuthorID] => 
                    [AuthorName] => 
                    [SectionName] => Science and Environment
                    [SectionUrl] => science-and-environment
                    [URL] => 
                )

        )

)

DUPHASTON

Array
(
    [results] => Array
        (
            [0] => Array
                (
                    [ArticleID] => 509392
                    [Title] => Abbott Laboratories acquires Belgian chemical maker for $6.6 billion
                    [Summary] => 
Abbott Laboratories on Monday said it would pay $6.6 billion for the pharmaceutical business of Belgian chemicals maker Solvay in a move to further expand internationally and add to its product portfolio.
                    [DatePublished] => 2009-09-30 00:00:00
                    [ColumnID] => 133272
                    [Focus] => 0
                    [AuthorID] => 
                    [AuthorName] => 
                    [SectionName] => Business
                    [SectionUrl] => business
                    [URL] => 
                )

            [1] => Array
                (
                    [ArticleID] => 175716
                    [Title] => New hope for women having miscarriages
                    [Summary] => The role of dydrogesterone (Duphaston) in reducing habitual abortions or recurrent miscarriages by making the immune system more receptive to pregnancy was recently discussed at a satellite symposium organized by Solvay Pharmaceuticals at the 9th World Congress of Gynecological Endocrinology in Hong Kong.


                    [DatePublished] => 2002-09-12 00:00:00
                    [ColumnID] => 133272
                    [Focus] => 0
                    [AuthorID] => 
                    [AuthorName] => 
                    [SectionName] => Science and Environment
                    [SectionUrl] => science-and-environment
                    [URL] => 
                )

        )

)

abtest

Abbott Laboratories acquires Belgian chemical maker for $6.6 billion

September 30, 2009 - 12:00am

Abbott Laboratories on Monday said it would pay $6.6 billion for the pharmaceutical business of Belgian chemicals maker Solvay in a move to further expand internationally and add to its product portfolio.

Business

New hope for women having miscarriages

September 12, 2002 - 12:00am

The role of dydrogesterone (Duphaston) in reducing habitual abortions or recurrent miscarriages by making the immune system more receptive to pregnancy was recently discussed at a satellite symposium organized by...

Science and Environment